Stockscreener 앱 받기
1.92
8.57%
-0.18
시간 외 거래:
1.95
0.03
+1.56%
전일 마감가:
$2.10
열려 있는:
$2.11
하루 거래량:
3.82M
Relative Volume:
0.57
시가총액:
$286.47M
수익:
-
순이익/손실:
$-14.07M
주가수익비율:
-0.1372
EPS:
-13.99
순현금흐름:
$-12.56M
1주 성능:
-18.64%
1개월 성능:
+6.67%
6개월 성능:
+164.83%
1년 성능:
-12.73%
1일 변동 폭
$1.92
$2.11
1주일 범위
$1.92
$2.55
52주 변동 폭
$0.53
$2.64
Palisade Bio Inc Stock (PALI) Company Profile
명칭
Palisade Bio Inc
전화
(858) 704-4900
주소
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
PALI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PALI
Palisade Bio Inc
|
1.92 | 313.33M | 0 | -14.07M | -12.56M | -13.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Palisade Bio Inc Stock (PALI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-29 | 개시 | Piper Sandler | Overweight |
Palisade Bio Inc 주식(PALI)의 최신 뉴스
Will Palisade Bio Inc. stock benefit from sector rotation2026 world cup usa national team third place match star players set piece tactics winner prediction expert opinion - Улправда
Palisade Bio (PALI) soars 5% ahead of clinical trial results - MSN
Wall Street Zen Upgrades Palisade Bio (NASDAQ:PALI) to "Hold" - MarketBeat
Risk Report: What is the fair value of Palisade Bio Inc stock now2025 Major Catalysts & Intraday High Probability Setup Alerts - moha.gov.vn
Palisade Bio Inc. (PALI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Analysts Are Bullish on These Healthcare Stocks: Palisade Bio (PALI), Centessa Pharmaceuticals (CNTA) - The Globe and Mail
Palisade Bio, Inc. (NASDAQ:PALI) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Palisade Bio (NASDAQ:PALI) Stock Rating Upgraded by Clear Str - MarketBeat
9,119,152 Common Stock of Palisade Bio, Inc. are subject to a Lock-Up Agreement Ending on 31-DEC-2025. - marketscreener.com
Certain Stock Options of Palisade Bio, Inc. are subject to a Lock-Up Agreement Ending on 31-DEC-2025. - marketscreener.com
Certain Restricted Stock Units of Palisade Bio, Inc. are subject to a Lock-Up Agreement Ending on 31-DEC-2025. - marketscreener.com
Certain Warrants of Palisade Bio, Inc. are subject to a Lock-Up Agreement Ending on 31-DEC-2025. - marketscreener.com
Palisade Bio receives patent approval in Japan for IBD drug PALI-2108 - Investing.com Nigeria
Palisade Bio Says Japan Grants Patent for Composition of PALI-2108 - marketscreener.com
Palisade Bio Secures Key Patent for PALI-2108, a Promising PDE4 Inhibitor for Ulcerative Colitis and Fibrostenotic Crohn’s Disease - Quiver Quantitative
New gut-targeted drug gains key patent in Japan for severe bowel disease - Stock Titan
Palisade Bio (NASDAQ:PALI) Upgraded at Piper Sandler - MarketBeat
Palisade Bio stock initiated with Buy rating at Clear Street on IBD drug potential - Investing.com
Palisade Bio Appoints New VP to Drive Further Growth - StocksToTrade
DigitalBridge Group, Eightco Holdings, Palisade Bio And Other Big Stocks Moving Higher On Monday - Benzinga
PALI’s Strategic Move: What’s Next? - timothysykes.com
Piper Sandler initiates Palisade Bio stock with Overweight rating on IBD drug By Investing.com - Investing.com Nigeria
Piper Sandler initiates Palisade Bio stock with Overweight rating on IBD drug - Investing.com Nigeria
Palisade Bio (PALI) Soars 5% Ahead of Clinical Trial Results - Finviz
10 Stocks Lighting Up Market Ahead of Christmas - Insider Monkey
Palisade Bio: Gut Prodrug For IBD With Catalysts - Seeking Alpha
Palisade Bio (PALI) upgraded to buy: Here's what you should know - MSN
Aug Summary: Is Palisade Bio Inc stock ready for breakout2025 Macro Impact & AI Enhanced Market Trend Forecasts - moha.gov.vn
Published on: 2025-12-21 10:03:36 - Улправда
How currency fluctuations impact Palisade Bio Inc. stock2025 Historical Comparison & Weekly Watchlist of Top Performers - Улправда
Why analysts remain bullish on Palisade Bio Inc. stock2025 Top Gainers & High Accuracy Investment Signals - Улправда
What earnings margins imply for Palisade Bio Inc. (7NS0) stockPortfolio Gains Summary & Weekly Top Stock Performers List - Улправда
Palisade Bio (NASDAQ:PALI) Stock Rating Lowered by Wall Street Zen - MarketBeat
Can Palisade Bio Inc. stock deliver surprise earnings beatWatch List & High Return Stock Watch Alerts - Улправда
How Palisade Bio Inc. stock reacts to bond yields2025 Performance Recap & Daily Entry Point Trade Alerts - Улправда
Is Palisade Bio Inc. stock a good choice for value investorsJuly 2025 Pullbacks & Low Risk Investment Opportunities - Улправда
Palisade Bio (PALI) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Aug Macro: How geopolitical risks impact Palisade Bio Inc. (7NS0) stock2025 Support & Resistance & Free High Accuracy Swing Entry Alerts - Улправда
Is Palisade Bio Inc. stock near bottom after decline2025 Trade Ideas & Smart Allocation Stock Tips - Улправда
Aug Final Week: Will Palisade Bio Inc. (7NS0) stock benefit from Fed rate cutsJuly 2025 Trade Ideas & Stepwise Trade Execution Plans - Улправда
How interest rate cuts could boost Palisade Bio Inc. stockTrade Risk Assessment & Capital Protection Trading Alerts - Улправда
Aug Opening: How geopolitical risks impact Palisade Bio Inc. (7NS0) stockMarket Growth Summary & Low Drawdown Momentum Ideas - Улправда
Will Palisade Bio Inc. (7NS0) stock benefit from Fed rate cutsJuly 2025 Big Picture & High Conviction Investment Ideas - Улправда
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Palisade Bio Inc - GuruFocus
Palisade Bio approves key proposals at stockholder meeting - MSN
Palisade Bio Stock Soars as Clinical Workforce Expands with New VP Appointment - StocksToTrade
Palisade Bio Stock Surge: What’s Behind the Rise? - StocksToTrade
Palisade Bio’s Vice President Appointment and UC Trial Success Boost Confidence - timothysykes.com
Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, ENVB, BDRX, HSPO, BRZE Surge Ahead of Fed Decision - ts2.tech
Palisade Bio (NASDAQ:PALI) Trading Up 0.6%Here's What Happened - MarketBeat
Palisade Bio Inc (PALI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
0.07%
자본화:
|
볼륨(24시간):